Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater

BMC Gastroenterology

Table 2 Clinical features and outcomes of patients

Case	Sex	Age range	Symptom	L/N ratio	Biopsy result	Operation	Adjuvant CTx	Recurrence site	Treatment for recurrence	Survival outcome
1	Female	50–59	Incidental	62.1%	NET	PPPD	Yes	NED		78 months alive
2	Male	60–69	Jaundice	15.8%	NET	PPPD	Yes	Liver	RFA, CTx	67 months dead
3	Female	50–59	Incidental	40.9%	NET	PPPD	Yes	NED		45 months alive
4	Male	30–39	Incidental	52.7%	NET	PD	Yes	NED		44 months alive
5	Male	60–69	Incidental	23.4%	NET	PD	No	liver	CTx	43 months alive

CTx chemotherapy, L/N ratio lymphocyte/neutrophil ratio, NED no evidence of disease, NET neuroendocrine tumor, PD pancreaticoduodenectomy, PPPD pylorus preserving pancreaticoduodenectomy, RFA radiofrequency ablation

ISSN: 1471-230X